Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.

Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia. N Engl J Med. 2014 Jul 17; 371(3):213-23.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.